MKS Instruments, Inc.
MKSI
Get informed when a big investor buys or sells
+ FollowEarnings Call Q1 2026
May 7, 2026 - AI Summary
Exclusive for Stockcircle Pro members
Sign up
Current Fair Value
92.1% downsideOvervalued by 92.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.90 Billion |
|---|---|
| Enterprise Value | $22.97 Billion |
| Dividend Yield | $0.69 (0.28%) |
| Earnings per Share | $4.39 |
| Beta | 1.97 |
| Outstanding Shares | 67,400,000 |
Return
| Return on Equity | 11.63% |
|---|---|
| Return on Assets | 3.75% |
| Return on Invested Capital | 9.32% |
Valuation & Multiples
| P/E Ratio | 66.84 |
|---|---|
| PEG | 108.61 |
| Price to Sales | 5.59 |
| Price to Book Ratio | 8.17 |
| Enterprise Value to Revenue | 5.64 |
| Enterprise Value to EBIT | 38.29 |
| Enterprise Value to Net Income | 70 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1001▼ 7.89% |
|---|---|
| Total Calls | 2,125,880▲ 8.20% |
| Total Puts | 212,800▼ 39.48% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 102.45%▼ 2.38% |
|---|---|
| Total Invested | $15.77B▲ 39.81% |
| Investors Holding | 634▲ 101.00% |
ESG Score
No data
About MKS Instruments, Inc.
CEO: John Lee MKS Instruments, Inc. is a global provider of instruments, systems, subsystems and process control solutions that measure, monitor, deliver, analyze, power and control critical parameters of advanced manufacturing processes to improve pr...
Relevant Senate Committees
This powerful committee controls taxation and trade. As a global provider, MKS Instruments is directly impacted by corporate tax policy and tariffs, which influence profitability, supply chains, and international competitiveness.
This committee directly allocates discretionary federal spending. For MKS Instruments, this means specific cash flows for defense programs and scientific research (key markets) are determined here, directly affecting their potential contract awards and order books.
MKS Instruments serves the 'life and health sciences' market. This committee's regulation of the FDA and NIH, including funding and drug approval processes, directly impacts their pharmaceutical and biotech customers, influencing demand for MKSI's instruments and solutions.
MKS Instruments explicitly serves the 'defense' market. This committee directly oversees the Department of Defense and authorizes the annual NDAA, making crucial decisions on R&D funding and procurement that directly impact MKSI's revenue streams in the defense sector.
MKS Instruments serves the defense market. This committee's oversight of the Intelligence Community and classified briefings on global threats could provide non-public material information directly impacting defense spending and procurement, which are crucial for MKSI's defense segment.
As a global provider for advanced manufacturing, MKS Instruments is directly impacted by U.S. foreign policy, sanctions, and trade relations. Geopolitical tensions, particularly affecting the semiconductor market, can influence their ability to operate internationally or source components.